Filing Details

Accession Number:
0001209191-17-045240
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-07-14 18:01:24
Reporting Period:
2017-07-03
Filing Date:
2017-07-14
Accepted Time:
2017-07-14 18:01:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1401667 Puma Biotechnology Inc. PBYI Pharmaceutical Preparations (2834) 770683487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1553037 Paul Richard Bryce C/O Puma Biotechnology, Inc.
10880 Wilshire Blvd., Suite 2150
Los Angeles CA 90024
Sr Vp, Clinical Research & Dev No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-07-03 5,000 $11.30 34,237 No 4 M Direct
Common Stock Disposition 2017-07-03 5,000 $87.10 29,237 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock STOCK OPTION (RIGHT TO BUY) Disposition 2017-07-03 5,000 $0.00 5,000 $11.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
97,000 2022-06-26 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
  2. The option is fully vested and is exercisable.